Geum.ru

Затверджено Постановою Кабінету Міністрів України від №

Вид материалаДокументы
Подобный материал:
1   ...   34   35   36   37   38   39   40   41   ...   63
o-toluidine; [1]

4-chloro-o-toluidine hydrochloride [2]

202-441-6 [1]

221-627-8 [2]


95-69-2 [1]

3165-93-3 [2]


Carc.Cat.2; R45

Muta.Cat.3; R68

T; R23/24/25

N; R50-53


T; N

R: 45-23/24/25-68-50/53

S: 53-45-60-61




2,4,5-trimethylaniline; [1]

2,4,5-trimethylaniline hydrochloride [2]

205-282-0 [1]

- [2]


137-17-7 [1]

21436-97-5 [2]


Carc.Cat.2; R45

T; R23/24/25

N; R51-53


T; N

R: 45-23/24/25-51/53

S: 53-45-61




4,4'-thiodianiline and its salts

205-370-9


139-65-1


Carc.Cat.2; R45

Xn; R22

N; R51-53


T; N

R: 45-22-51/53

S: 53-45-61




4,4'-oxydianiline and its salts;

p-aminophenyl ether

202-977-0


101-80-4


Carc.Cat.2; R45

Muta.Cat.2; R46

Repr.Cat.3; R62

T; R23/24/25

N; R51-53


T; N

R: 45-46-23/24/25-62-51/53

S: 53-45-61




2,4-diaminoanisole;

4-methoxy-m-phenylenediamine; [1]

2,4-diaminoanisole sulphate [2]

210-406-1 [1]

254-323-9 [2]


615-05-4 [1]

39156-41-7 [2]


Carc.Cat.2; R45

Muta.Cat.3; R68

Xn; R22

N; R51-53


T; N

R: 45-22-68-51/53

S: 53-45-61




N,N,N',N'-tetramethyl-4,4'-methylendianiline

202-959-2


101-61-1


Carc.Cat.2; R45

N; R50-53


T; N

R: 45-50/53

S: 53-45-60-61




3,4-dichloroaniline

202-448-4


95-76-1


T; R23/24/25

Xi; R41

R43

N; R50-53


T; N

R: 23/24/25-41-43-50/53

S: (1/2-)26-36/37/39-45-60-61




C.I. Basic Violet 3;

4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride

208-953-6


548-62-9


Carc.Cat.3; R40

Xn; R22

Xi; R41

N; R50-53


Xn; N

R: 22-40-41-50/53

S: (2-)26-36/37/39-46-60-61




C.I. Basic Violet 3 with ≥ 0.1% of Michler's ketone (EC no. 202-027-5)

208-953-6


548-62-9


Carc.Cat.2; R45

Xn; R22

Xi; R41

N; R50-53


T; N

R: 45-22-41-50/53

S: 53-45-60-61




famoxadone;

3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione

-


131807-57-3


Xn; R48/22

N; R50-53


Xn; N

R: 48/22-50/53

S: (2-)46-60-61




4-ethoxyaniline;

p-phenetidine

205-855-5


156-43-4


Muta. Cat. 3; R68

Xn; R20/21/22

Xi; R36

R43


Xn

R: 20/21/22-36-43-68

S: (2-)36/37-46




6-methoxy-m-toluidine;

p-cresidine

204-419-1


120-71-8


Carc.Cat.2; R45

Xn; R22


T

R: 45-22

S: 53-45




5-nitro-o-toluidine; [1]

5-nitro-o-toluidine hydrochloride [2]

202-765-8 [1]

256-960-8 [2]


99-55-8 [1]

51085-52-0 [2]


Carc.Cat.3; R40

T; R23/24/25

R52-53


T

R: 23/24/25-40-52/53

S: (1/2-)36/37-45-61




N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide

416-470-9


-


Xi; R36

N; R51-53


Xi; N

R: 36-51/53

S: (2-)26-61




2,6-dichloro-4-trifluoromethylaniline

416-430-0


24279-39-8


Xn; R20/22

Xi; R38

R43

N; R50-53


Xn; N

R: 20/22-38-43-50/53

S: (2-)24-37-60-61




isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine

419-850-2


148348-13-4


C; R34

R52-53


C

R: 34-52/53

S: (1/2-)23-26-36/37/39-45-61




4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine

421-390-2


89114-90-9


R 53



R: 53

S: 61




3-chloro-2-(isopropylthio)aniline

421-700-6


179104-32-6


Xi; R38

N; R51-53


Xi; N

R: 38-51/53

S: (2-)37-61




1-methoxy-2-propylamine

422-550-4


37143-54-7


F; R11

C; R34

Xn; R22

R52-53


F; C

R: 11-22-34-52/53

S: (1/2-)9-26-36/37/39-45-61




ethyleneimine;

aziridine

205-793-9


151-56-4


F; R11

Carc. Cat. 2; R45

Muta. Cat. 2; R46

T+; R26/27/28

C; R34

N; R51-53


F; T+; N

R: 45-46-11-26/27/28-34-51/53

S: 53-45-61




pyridine

203-809-9


110-86-1


F; R11

Xn; R20/21/22


F; Xn

R: 11-20/21/22

S: (2-)26-28

C ≥ 5 %: Xn; R20/21/22


1,2,3,4-tetranitrocarbazole

-


6202-15-9


E

R1

Xn; R20/21/22


E; Xn

R: 1-20/21/22

S: (2-)35




crimidine (ISO);

2-chloro-6-methylpyrimidin-4-yldimethylamine

208-622-6


535-89-7


T+; R28


T+

R: 28

S: (1/2-)36/37-45




desmetryne (ISO);

6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine

213-800-1


1014-69-3


Xn; R21/22

N; R50-53


Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61




dazomet (ISO);

tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione

208-576-7


533-74-4


Xn; R22

Xi; R36

N; R50-53


Xn; N

R: 22-36-50/53

S: (2-)15-22-24-60-61




2,4,6-trichloro-1,3,5-triazine;

cyanuric chloride

203-614-9


108-77-0


T+; R26

Xn; R22

C; R34

R43

R14


T+; C

R: 14-22-26-34-43

S: (1/2-)26-28-36/37/39-45-46-63

C ≥ 25 %: T+; R22-26-34-43

10 % ≤ C < 25 %: T+; R26-34-43

7 % ≤ C < 10 %: T+; R26-36/37/38-43

5 % ≤ C < 7 %: T; R23-36/37/38-43

1 % ≤ C < 5 %: T; R23-43

0,1 % ≤ C < 1 %: Xn; R20


ametryn (ISO);

2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine

212-634-7


834-12-8


Xn; R22

N; R50-53


Xn; N

R: 22-50/53

S: (2-)36-60-61




amitrole (ISO);

1,2,4-triazol-3-ylamine

200-521-5


61-82-5


Repr.Cat.3; R63

Xn; R48/22

N; R51-53


Xn; N

R: 48/22-63-51/53

S: (2-)13-36/37-61




bentazone (ISO);

3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide

246-585-8


25057-89-0


Xn; R22

Xi; R36

R43

R52-53


Xn

R: 22-36-43-52/53

S: (2-)24-37-61




cyanazine (ISO);

2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile

244-544-9


21725-46-2


Xn; R22

N; R50-53


Xn; N

R: 22-50/53

S: (2-)37-60-61




ethoxyquin;

6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline

202-075-7


91-53-2


Xn; R22


Xn

R: 22

S: (2-)24




fenazaflor (ISO);

phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate

238-134-9


14255-88-0


Xn; R21/22

N; R50-53


Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61




fuberidazole;

2-(2-furyl)benzimidazole

223-404-0


3878-19-1


Xn; R22

N; R50-53


Xn; N

R: 22-50/53

S: (2-)22-60-61




bis (8-hydroxyquinolinium) sulphate

205-137-1


134-31-6


Xn; R22


Xn

R: 22

S: (2-)36




morfamquat (ISO);

1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion

-


7411-47-4


Xn; R22

Xi; R36/37/38

R52-53


Xn

R: 22-36/37/38-52/53

S: (2-)22-36-61




thioquinox;

2-thio-1,3-dithiolo(4,5,b)quinoxaline

202-272-8


93-75-4


Xn; R22


Xn

R: 22

S: (2-)24




tridemorph (ISO);

2,6-dimethyl-4-tridecylmorpholine

246-347-3


24602-86-6


Repr. Cat. 2; R61

Xn; R20/22

Xi; R38

N; R50-53


T; N

R: 61-20/22-38-50/53

S: 53-45-60-61




dithianon (ISO);

5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile

222-098-6


3347-22-6


Xn; R22

N; R50-53


Xn; N

R: 22-50/53

S: (2-)24-60-61




pyrethrins including cinerins

-


-


Xn; R20/21/22

N; R50-53


Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61




2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;

pyrethrin I

204-455-8


121-21-1


Xn; R20/21/22

N; R50-53


Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61




2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

pyrethrin II

204-462-6


121-29-9


Xn; R20/21/22

N; R50-53


Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61




cinerin I;

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate

246-948-0


25402-06-6


Xn; R22

N; R50-53


Xn; N

R: 22-50/53

S: (2-)60-61




cinerin II;

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate

204-454-2


121-20-0


Xn; R22

N; R50-53


Xn; N

R: 22-50/53

S: (2-)60-61




piperidine

203-813-0


110-89-4


F; R11

T; R23/24

C; R34


F; T

R: 11-23/24-34

S: (1/2-)16-26-27-45

C ≥ 5 %: T; R23/24-34

1 % ≤ C < 5 %: Xn; R20/21-36/38


morpholine

203-815-1


110-91-8


R10

Xn; R20/21/22

C; R34


C

R: 10-20/21/22-34

S: (1/2-)23-36-45

C ≥ 25 %: C; R20/21/22-34

10 % ≤ C < 25 %: C; R34

1 % ≤ C < 10 %: Xi; R36/38


dichloro-1,3,5-triazinetrione;

dichloroisocyanuric acid

220-487-5


2782-57-2


O; R8

Xn; R22

R31

Xi; R36/37

N; R50-53


O; Xn; N

R: 8-22-31-36/37-50/53

S: (2-)8-26-41-60-61




troclosene potassium; [1]

troclosene sodium [2]

218-828-8 [1]

220-767-7 [2]


2244-21-5 [1]

2893-78-9 [2]


O; R8

Xn; R22

R31

Xi; R36/37

N; R50-53


O; Xn; N

R: 8-22-31-36/37-50/53

S: (2-)8-26-41-60-61

C ≥ 10 %: Xn; R22-31-36/37


troclosene sodium, dihydrate

220-767-7


51580-86-0


Xn; R22

R31

Xi; R36/37

N; R50-53


Xn; N

R: 22-31-36/37-50/53

S: (2-)8-26-41-60-61




symclosene;

trichloroisocyanuric acid;

trichloro-1,3,5-triazinetrion

201-782-8


87-90-1


O; R8

Xn; R22

R31

Xi; R36/37

N; 50-53


O; Xn; N

R: 8-22-31-36/37-50/53

S: (2-)8-26-41-60-61




methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;

2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine

236-035-5


13108-52-6


Xn; R21/22

Xi; R36

R43


Xn

R: 21/22-36-43

S: (2-)26-28




2-methylaziridine;

propyleneimine

200-878-7


75-55-8


F; R11

Carc. Cat. 2; R45

T+; R26/27/28

Xi; R41

N; R51-53


F; T+; N

R: 45-11-26/27/28-41-51/53

S: 53-45-61

C ≥ 25 %: T+, N; R45-26/27/28-41-51/53

10 % ≤ C < 25 %: T+; R45-26/27/28-41-52/53

7 % ≤ C < 10 %: T+; R45-26/27/28-36-52/53

5 % ≤ C < 7 %: T; R45-23/24/25-36-52/53

2,5 % ≤ C < 5 %: T; R45-23/24/25-52/53

1 % ≤ C < 2,5 %: T; R45-23/24/25

0,1 % ≤ C < 1 %: T; R45-20/21/22

0,01 % ≤ C < 0,1 %: T; R45


1,2-dimethylimidazole

217-101-2


1739-84-0


Xn; R22

Xi; R38-41


Xn

R: 22-38-41

S: (2-)24-26




1-methylimidazole

210-484-7


616-47-7


Xn; R21/22

C; R34


C

R: 21/22-34

S: (1/2-)26-36-45




2-methylpyridine;

2-picoline

203-643-7


109-06-8


R10

Xn; R20/21/22

Xi; R36/37


Xn

R: 10-20/21/22-36/37

S: (2-)26-36




4-methylpyridine;

4-picoline

203-626-4


108-89-4


R10

T; R24

Xn; R20/22

Xi; R36/37/38


T

R: 10-20/22-24-36/37/38

S: (1/2-)26-36-45




6-phenyl-1,3,5-triazine-2,4-diyldiamine;

6-phenyl-1,3,5-triazine-2,4-diamine;

benzoguanamine

202-095-6


91-76-9


Xn; R22

R52-53


Xn

R: 22-52/53

S: (2-)61




ethylene thiourea;

imidazolidine-2-thione;

2-imidazoline-2-thiol

202-506-9


96-45-7


Repr. Cat. 2; R61

Xn; R22


T

R: 61-22

S: 53-45




azaconazole (ISO);

1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1